fullerene c60 has been researched along with busulfan in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (busulfan) | Trials (busulfan) | Recent Studies (post-2010) (busulfan) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 4,967 | 645 | 1,426 |
| Protein | Taxonomy | fullerene c60 (IC50) | busulfan (IC50) |
|---|---|---|---|
| Matrix metalloproteinase-9 | Homo sapiens (human) | 5.215 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, C; Jia, W; Li, J; Li, L; Liu, S; Sun, Z; Wang, C; Zhao, Z; Zhen, M; Zhou, C | 1 |
1 other study(ies) available for fullerene c60 and busulfan
| Article | Year |
|---|---|
Gadofullerene nanoparticles for robust treatment of aplastic anemia induced by chemotherapy drugs.
Topics: Anemia, Aplastic; Animals; Antineoplastic Agents, Alkylating; Bone Marrow Cells; Busulfan; Cell Differentiation; Cyclophosphamide; Disease Models, Animal; Erythropoiesis; Erythropoietin; Female; Fullerenes; Hematopoietic Stem Cells; Mice; Mice, Inbred ICR; Nanoparticles | 2020 |